Accupac competitors

C-Level Executive with demonstrated leadership skills and proven business results in Pharmaceuticals (Branded and Generics), Sales, Marketing, Operations, Business Development, R&D/Regulatory.I'm a creative problem-solver, with a track record of outstanding results through professional and interpersonal skills including strategic vision, team development, people management, prioritization, motivation, decisiveness and grit.

Dr. Ellison has served as our President and Chief Executive Officer since April 2020 and as a Director on our Board since January 2020. Dr. Ellison’s broad experience and leadership positions include Chief Executive Officer of the privately held biotechnology company, Promedior, Inc. (acquired by Roche); President and Chief Executive Officer of Bond Biosciences, Inc., a biotech start-up developing a drug addressing the toxic impact of iron overload in the body; Executive Director of Torreya Advisors, LLC, a life sciences investment banking firm; Chairman and Chief Executive Officer of Assembly Biosciences, Inc. (formerly Ventrus Biosciences, Inc.); Executive Vice President of Paramount Biosciences LLC, a global drug development and healthcare investment firm; Vice President of Clinical Development of FibroGen, Inc., where he played a key role in the early phase development of roxadustat in anemia for chronic kidney disease (CKD) patients; Vice President of Medical Affairs and Chief Medical Officer of Sanofi-Synthelabo US, Inc.; and Vice President, Medical Affairs and Chief Medical Officer of Hoffman La Roche, Inc. in the United States. Dr. Ellison previously served as an Independent Board Director for several private and public companies, including Cougar Biotechnology Inc.; ProSanos Corporation; Cormedix Inc., a cardio-renal clinical stage company; and Mt. Cook, a urology-focused company. Dr. Ellison received a Master of Science degree from the London School of Tropical Medicine and Hygiene, and an M.D. from the University of British Columbia.

Mr. John Golubieski is a President and Chief Executive Officer at Fougera Pharmaceuticals Inc and is based in United States.

Jim Emme is a CEO at NOW Foods and is based in Greater Chicago Area. He studied at Purdue University.

A strategic global executive with extensive experience building high performance teams which deliver both top and bottom line growth while increasing operating funds. A proven track record of managing businesses, with full P&L responsibilities in the durable goods industries with both manufacturing and distribution internationally. Known for managing turn around, acquisitions, strategic planning, innovation, organizational effectiveness and building customer loyalty. Strong communicator able to motivate organizations around the common financial and strategic goals and deliver consistent results. Specialties: •Strategic Visioning •Global Manufacturing & Sourcing •Financial Acumen •Innovative Product Development •Global Selling and Distribution •Accountable •Mergers & Acquisitions •Global Capital Management •Builds Trust

Gregory Pulido is a Chairman and Chief Executive Officer at HUMCO and is based in Austin, Texas. He studied at Arizona State University.

George Hanford is a Chief Executive Officer at Hanford Pharmaceuticals and is based in Syracuse, New York.